社会不安障害治療のストラテジー

出版社： 先端医学社
著者：
発行日： 2005-06-15
分野： 臨床医学：内科  >  精神医学
ISBN： 4884071883
電子書籍版： 2005-06-15 （第1版第1刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

4,620 円(税込)

購入する
電子書籍
章別単位で購入
ブラウザ、アプリ閲覧

2,310 円(税込)

購入する

商品紹介

人生そのものにも障害をきたすことの多い社会不安障害に対し、SSRIを中心とした薬物療法から森田療法、認知行動療法まで、多角度から治療戦略を検討。DSM、ICDにもとづいた鑑別診断や、アルコール障害などとの合併症についても詳述。治療に取り組む医療従事者必読の一冊。

目次

  • 社会不安障害治療のストラテジー

    ―目次―

    Part.1　社会不安障害の概要と病態の特徴
    　１．社会不安障害とは―概念および定義―
    　２．対人恐怖症と社会不安障害―その概念と相互関係―
    　３．社会不安障害の原因と症状の特徴
    　４．社会不安障害の有病率―罹病年齢などの疫学から―
    　５．社会不安障害の社会的コストへの影響
    Part.2　社会不安障害の生物学的特徴と治療アプローチ
    　１．社会不安障害と扁桃体関連のネットワーク
    　２．社会不安障害に対するセロトニンの役割とSSRIの作用機序
    　３．社会不安障害の遺伝性に関する考察
    Part.3　社会不安障害の評価尺度および診断
    　１．社会不安障害の分類と鑑別診断
    　２．DSM-?およびICD-10における
    　　　　「社会不安障害」診断基準の特徴
    　３．社会不安障害の診断とLiebowitz Social Anxiety
    　　　　Scale(LSAS)による臨床評価（日本語版含む）
    Part.4　合併症を伴った社会不安障害
    　１．パニック障害と社会不安障害
    　２．心的外傷後ストレス障害と社会不安障害
    　３．うつ病患者と社会不安障害
    　４．その他の疾患と合併した社会不安障害
    　　　　―アルコール症（依存･乱用）,摂食障害など―
    Part.5　社会不安障害の治療の考え方とストラテジー
    　１．社会不安障害の患者への病態説明のポイント
    　　　　―心理教育的態度を重視する立場から―
    　２．社会不安障害の治療のアルゴリズムを勘案する
    　　　　―治療の選択基準と手順―
    　３．社会不安障害における薬物療法の位置づけ
    　４．認知行動療法
    　５．社会不安障害/対人恐怖症の森田療法
    Part.6　社会不安障害の薬物療法による治療ストラテジー
    　１．社会不安障害の症状に応じた薬剤の選択とその基準
    　２．社会不安障害に対するSSRIの効果
    　３．社会不安障害の薬物療法におけるSSRIの
    　　　　至適用量と治療期間
    　４．社会不安障害の長期薬物療法の実際
    　５．症例からみた社会不安障害の治療の実際
    Part.7　社会不安障害の治療評価を検証する
    　１．社会不安障害の治療がQOLの向上に与える影響
    　２．社会不安障害の経過観察と治療評価
    　３．治療薬剤の副作用とその対応
    　４．薬剤併用による薬物間相互作用
    　５．薬物療法のコンプライアンス向上を図る服薬指導

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

part1 / 社会不安障害の概要と病態の特徴

P.6 掲載の参考文献
1) American Psychiatric Association:In:Diagnostic and Statistical Manual of Mental Disorders, Third Edition. APA, Washington DC, 1980
 
2) American Psychiatric Association:In:Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. APA, Washington DC, 1994
 
3) Stein DJ:Pharmacotherapy of social anxiety disorder. 臨床精神薬理 5:440-447, 2002
 
4) World Health Organization:In:The ICD-10 Classification Of Mental and Behavioural Disorders:Clinical Descriptions and Diagnostic Guidelines. WHO, Geneva, 1992
 
5) 笠原敏彦:対人恐怖と社会恐怖 (ICD-10) の診断について. 精神神経学雑誌 97:357-366, 1995
 
6) 笠原敏彦:社会恐怖症. 臨床精神医学講座第5巻神経症性障害・ストレス関連障害, 中山書店, 東京, 1997, pp. 116-127
 
P.11 掲載の参考文献
1) American Psychiatric Association:In:Diagnostic and Statistical Manual Of Mental Disorders, Fourth Edition. APA, Washington DC, 1994
 
2) Liebowitz MR et al:Social phobia. Review of a neglected anxiety disorder. Arch Gen Psychiatry 42:729-736, 1985
PubMed
3) 森田正馬:神経質の本態と療法-精神生活の開眼. 白揚社, 東京, 1960
 
4) 笠原嘉ほか:正視恐怖・体臭恐怖-主として精神分裂病との境界例について. 医学書院, 東京, 1972
 
5) 高橋徹:対人恐怖症-相互伝達の分析-. 医学書院, 東京, 1976
 
6) 内沼幸雄:対人恐怖症の人間学. 弘文堂, 東京, 1977
 
7) 山下格:対人恐怖. 金原出版, 東京, 1977
 
8) Nagata T et al:Open trial of milnacipran for Taijin Kyofusho in Japanese patients with social anxiety disorder. Int J Psych Clin Pract 7:107-112, 2003
 
9) 永田利彦ほか:社会不安障害に対する薬物療法:古典的対人恐怖, ひきこもりとの関連. 精神医学 46:933-939, 2004
 
10) 永田利彦ほか:社会不安障害患者における大うつ病性障害の生涯診断. 精神医学 46:381-387, 2004
 
11) Marks IM et al:Different ages of onset in varieties of phobia. Am J Psychiatry 123:218-221, 1966
PubMed
12) 笠原敏彦:対人恐怖症と社会恐怖(ICD-10)の診断について. 精神神経学雑誌 97:357-366, 1995
 
13) 朝倉聡ほか:対人恐怖症/社会恐怖の薬物療法. 臨床精神医学 29:1121-1128, 2000
 
14) 永田利彦ほか:治験広告によって来院した社会不安障害例. 精神医学 45:709-714, 2003
 
15) 永田利彦ほか:社会不安障害における価値観:古典的対人恐怖との関連. 精神医学 46:141-147, 2004
 
16) Seedat S et al:Cross-cultural aspects of social anxiety disorder. In:Social Anxiety Disorder-More Than Shyness; Psychopathology, Pathogenesis, and Management, ed. by Bandelow B et al, Marcel Dekker, New York, 2004, pp. 117-130
 
17) Eisen JL et al:Insight in obsessive compulsive disorder and body dysmorphic disorder. Compr Psychiatry 45:10-15, 2004
PubMed
18) 永田利彦ほか:社会不安障害におけるパーソナリティー障害:大うつ病性障害との関連. 精神医学 46:685-690, 2004
 
P.18 掲載の参考文献
1) American Psychiatric Association:In:Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. APA, Washington DC, 1987
 
2) 小山司ほか:社会不安障害(SAD)の診断と薬物療法. 分子精神医学 3:55-61, 2003
 
3) Sheehan DV:社会不安障害の典型例. 社会不安障害-Social Anxiety Disorder, 樋口輝彦ほか編, 日本評論社, 東京, 2002, pp. 27-31
 
4) 貝谷久宣ほか:我が国における社会不安障害の特徴と治療の実際. 臨床精神薬理 6:1309-1320, 2003
 
5) Rosenbaum JF et al:The etiology of social phobia. J Clin Psychiatry 55:10-16, 1994
PubMed
6) Fyer AJ et al:A direct interview family study of social phobia. Arch Gen Psychiatry 50:286-293, 1993
PubMed
7) Delprato DJ et al:Behavioral theories of anxiety disorders. In:Behavioral Theory and the Treatment Of Anxiety, ed. by Turner S, Plenum Press, New York, 1984, pp. 1-49
 
8) Bruch M et al:Social phobia and perceptions of early parental and personal characteristics. Anx Res 2:57-65, 1989
 
9) Kasper S:Social phobia:the nature of the disorder. J Affect Disord 50(suppl 1):S3-S9, 1998
 
10) Tancer ME:Neurobiology of social phobia. J Clin Psychiatry 54(suppl):S26-S30, 1993
 
11) Tancer ME et al:Neuroendocrine responsivity to monoaminergic system probes in generalized social phobia. Anxiety 1:216-223, 1994-1995
 
12) Schneier FR et al:Low dopamine D(2) receptor binding potential in social phobia. Am J Psychiatry 157:457-459, 2000
PubMed
13) Tiihonen J et al:Dopamine reuptake site densities in patients with social phobia. Am J Psychiatry 154:239-242, 1997
PubMed
14) Stein MB et al:Lymphocyte β-adrenoceptors in social phobia. Biol Psychiatry 34:45-50, 1993
 
15) Papp LA et al:Epinephrine infusions in patients with social phobia. Am J Psychiatry 145:733-736, 1988
PubMed
16) Davidson JR et al:Magnetic resonance spectroscopy in social phobia:preliminary findings. J Clin Psychiatry 54(suppl):S19-S25, 1993
 
17) 永田利彦:社会不安障害における生物学的研究. 臨床精神薬理 6:1287-1292, 2003
 
18) Furmark T et al:Common changes in cerebral blood flow in patients with social phobia treated with citalopram or cognitive-behavioral therapy. Arch Gen Psychiatry 59:425-433, 2002
PubMed
P.25 掲載の参考文献
1) Furmark T:Social phobia:overview of community surveys. Acta Psychiatr Scand 1O5:84-93, 2002
 
2) Stein MB et al:Setting diagnostic thresholds for social phobia:considerations from a community survey of social anxiety. Am J Psychiatry 151:408-412, 1994
PubMed
3) Furmark T et al:Social phobia subtypes in the general population revealed by cluster analysis. Psychol Med 30:1335-1344, 2000
PubMed
4) Magee WJ et al:Agoraphobia, simple phobia, and social phobia in the National Comorbidity Survey. Arch Gen Psychiatry 53:159-168, 1996
PubMed
5) Weissman MM et al:Psychiatric disorders in a U.S. urban community:1975-1976. Am J Psychiatry 135:459-462, 1978
 
6) Regier DA et al:The NIMH Epidemiologic Catchment Area program. Historical context, major objectives, and study population characteristics. Arch Gen Psychiatry 41:934-941, 1984
PubMed
7) Myers JK et al:Six-month prevalence of psychiatric disorders in three communities 1980 to 1982. Arch Gen Psychiatry 41:959-967, 1984
PubMed
8) Schneier FR et al:Social phobia. Comorbidity and morbidity in an epidemiologic sample. Arch Gen Psychiatry 49:282-288, 1992
 
9) Bourdon KH et al:Gender differences in phobias:results of the ECA community survey. J Anxiety Disord 2:227-241, 1988
 
10) Davidson JR et al:The epidemiology of social phobia:findings from the Duke Epidemiological Catchment Area Study. Psychol Med 23:709-718, 1993
PubMed
11) Robins LN et al:National Institute of Mental Health Diagnostic Interview Schedule. Its history, characteristics, and validity. Arch Gen Psychiatrv 38:381-389, 1981
PubMed
12) Karno M et al:Lifetime prevalence of specific psychiatric disorders among Mexican Americans and non-Hispanic whites in Los Angeles. Arch Gen Psychiatry 44:695-701, 1987
PubMed
13) George LK et al:Urban/rural differences in the prevalence of anxiety disorder. Am J Soc Psychiatry 6:249-258, 1986
 
14) Bland RC et al:Lifetime prevalence of psychiatric disorders in Edmonton. Acta Psychiatr Scand 338(suppl):S24-S32, 1988
 
15) Wells JE et al:Christchurch Psychiatric Epidemiology Study, Part I:Methodology and lifetime prevalence for specific psychiatric disorders. Aust N Z J Psychiatry 23:315-326, 1989
PubMed
16) Walker JR et al:Epidemiology. In:Social Phobia-Clinical and Research Perspective, ed. by Stein MB, American Psychiatric Press, Washington DC, 1995, pp. 43-75
 
17) Canino GJ et al:The prevalence of specific psychiatric disorders in Puerto Rico. Arch Gen Psychiatry 44:727-735, 1987
PubMed
18) Hwu HG et al:Prevalence of psychiatric disorders in Taiwan defined by the Chinese Diagnostic Interview Schedule. Acta Psychiatr Scand 79:136-147, 1989
PubMed
19) Lee CK et al:Psychiatric epidemiology in Korea. Part I:Gender and age differences in Seoul. J Nerv Ment Dis 178:242-246, 1990
PubMed
20) Stefansson JG et al:Lifetime prevalence of specific mental disorders among people born in Iceland in 1931. Acta Psychiatr Scand 84:142-149, 1991
PubMed
21) Faravelli C et al:Epidemiology of anxiety disorders in Florence. Acta Psychiatr Scand 79:308-312, 1989
PubMed
22) Faravelli C et al:Epidemiology of social phobia:a clinical approach. Eur Psychiatry 15:17-24, 2000
PubMed
23) Pollard CA et al:Four types of social phobia in a community sample. J Nerv Ment Dis 176:440-445, 1988
 
24) Kessler RC et al:Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 51:8-19, 1994
PubMed
25) Kessler RC et al:Social phobia subtypes in the National Comorbidity Survey. Am J Psychiatry 155:613-619, 1998
PubMed
26) Wittchen HU et al:Social fears and social phobia in a community sample of adolescents and young adults:prevalence, risk factors and co-morbidity. Psychol Med 29 309-323, 1999
 
27) Chartier MJ et al:Lifetime patterns of social phobia:a retrospective study of the course of social phobia in a nonclinical population. Depress Anxiety 7:113-121, 1998
 
28) Burns LE:The epidemiology of fears and phobias in general practice. J Int Med Res 8(suppl 3):S1-S7, 1980
 
29) Reich J:The epidemiology of anxiety. J Nerv Ment Dis 174:129-136, 1986
PubMed
30) Moutier CY et al:The history, epidemiology, and differential diagnosis of social anxiety disorder. J Clin Psychiatry 60(suppl 9):S4-S8, 1999
 
31) van den Brink W et al:Mental health intervention programs in primary care:their scientific basis. J Affect disord 21:273-284, 1991
PubMed
32) 0lfson M et al:Mental disorders and disability among patients in a primary care group practice. Am J Psychiatry 154:1734-1740, 1997
 
33) Weiller E et al:Social phobia in general health care:an unrecognised undertreated disabling disorder. Br J Psychiatry 168:169-174, 1996
PubMed
34) Stein MB et al:Social phobia in the primary care medical setting. J Fam Pract 48:514-519, 1999
PubMed
35) de Rijk C et al:Prevalence of mental disorders in persons with Parkinson's disease. Ned Tijdschr Geneeskd 142:27-31, 1998
PubMed
36) Weisskopf MG et al:Prospective study of phobic anxiety and risk of Parkinson's disease. Mov Disord 18:646-651, 2003
PubMed
37) Holt CS et al:Situational domains of social phobia. J Anxiety Disord 6:63-77, 1992
 
38)Turner SM et al:Social phobia:a comparison of specific and generalized subtypes and avoidant personality disorder. J Abnorm Psychol 101:326-331, 1992
PubMed
39) Heimberg RG et al:DSM-III-R subtypes of social phobia. Comparison of generalized social phobics and public speaking phobics. J Nerv Ment Dis 178:172-179, 1990
PubMed
40) Weinshenker NJ et al:Profile of a large sample of a patients with social phobia:comparison between generalized and specific social phobia. Depress Anxiety 4:209-216, 1996-1997
 
P.32 掲載の参考文献
1) 李啓充:理念なき医療『改革』を憂える. 週刊医学界新聞 2469, 医学書院, 東京, 2002 (http://www.igaku-shoin.co.jp/nwsppr/n2002dir/n2469dir/n2469_03.htm#00)
 
2) Patel A et al:The economic consequences of social phobia. J Affect Disord 68:221-233, 2002
PubMed
3) Katzelnick DJ et al:Impact of generalized social anxiety disorder in managed care. Am J Psychiatry 158:1999-2007, 2001
PubMed
4) Wittchen HU et al:The impact of social phobia on quality of life. Int Clin Psychopharmacol 11:15-23, 1996
PubMed
5) Magee WJ et al:Agoraphobia, simple phobia, and social phobia in the National Comorbidity Survey. Arch Gen Psychiatry 53:159-168, 1996
PubMed
6) Schneier FR et al:Functional impairment in social phobia. J Clin Psychiatry 55:322-331, 1994
PubMed
7) Gould RA et al:Cognitive-behavioral and pharmacological treatment for social phobia:A metaanalysis. Clinical Psychology:Science and Practice 4:291-306, 1997
 
8) Radomsky AS et al:Cognitive-behavioral therapy for social anxiety disorder. Psychiatr Clin North Am 24:805-815, 2001
PubMed
9) Wittchen HU et al:Social fears and social phobia in a community sample of adolescents and young adults:prevalence, risk factors and co-morbidity. Psychol Med 29:309-323, 1999
 
10) Wittchen HU et al:Epidemiology and natural course of social fears and social phobia. Acta Psychiatr Scand 108:4-18, 2003
 
11) 高橋徹:恐怖とイメージ. 金剛出版, 東京, 1979, pp. 148-168
 

part2 / 社会不安障害の生物学的特徴と治療アプローチ

P.37 掲載の参考文献
1) Davidson RJ et al:Anxiety and affective style:role of prefrontal cortex and amygdala. Biol Psychiatry 51:68-80, 2002
PubMed
2) Petrovich GD et al:Combinatorial amygdalar inputs to hippocampal domains and hypothalamic behavior systems. Brain Res Brain Res Rev 38:247-289, 2001
PubMed
3) Tillfors M et al:Cerebral blood flow in subjects with social phobia during stressful speaking tasks:a PET study. Am J Psychiatry 158:1220-1226, 2001
PubMed
4) Stein MB et al:Increased amygdala activation to angry and contemptuous faces in generalized social phobia. Arch Gen Psychiatry 59:1027-1034, 2002
PubMed
5) Simpson JR Jr et al:Emotion-induced changes in human medial prefrontal cortex:I. During cognitive task performance. Proc Natl Acad Sci U S A 98:683-687, 2001
PubMed
6) Rauch SL et al:Exaggerated amygdala response to masked facial stimuli in posttraumatic stress disorder:a functional MRI study. Biol Psychiatry 47:769-776, 2000
PubMed
7) Sheline YI et al:Increased amygdala response to masked emotional faces in depressed subjects resolves with antidepressant treatment:an fMRI study. Biol Psychiatry 50:651-658, 2001
PubMed
8) Birbaumer N et al:fMRI reveals amygdala activation to human faces in social phobics. Neuroreport 9:1223-1226, 1998
PubMed
9) Schneider F et al:Subcortical correlates of differential classical conditioning of aversive emotional reactions in social phobia. Biol Psychiatry 45:863-871, 1999
PubMed
10) Veit R et al:Brain circuits involved in emotional learning in antisocial behavior and social phobia in humans. Neurosci Lett 328:233-236, 2002
PubMed
11) Davidson RJ et al:Dysfunction in the neural circuitry of emotion regulation-a possible prelude to violence. Science 289:591-594, 2000
PubMed
12) Garcia R et al:The amygdala modulates prefrontal cortex activity relative to conditioned fear. Nature 402:294-296, 1999
PubMed
13) Adolphs R et al:The human amygdala in social judgment. Nature 393:470-474, 1998
PubMed
14) Anderson AK et al:Lesions of the human amygdala impair enhanced perception of emotionally salient events. Nature 411:305-309, 2001
PubMed
15) Adolphs R et al:Recognition of facial emotion in nine individuals with bilateral amygdala damage. Neuropsychologia 37:1111-1117, 1999
PubMed
16) Paradiso S et al:Cerebral blood flow changes associated with attribution of emotional valence to pleasant, unpleasant, and neutral visual stimuli in a PET study of normal subjects. Am J Psychiatry 156:1618-1629, 1999
 
17) Furmark T et al:Common changes in cerebral blood flow in patients with social phobia treated with citalopram or cognitive-behavioral therapy. Arch Gen Psychiatry 59:425-433, 2002
PubMed
P.44 掲載の参考文献
1) Blanco C et al:Pharmacotherapy of social anxiety disorder. Biol Psychiatry 51:109-120, 2002
PubMed
2) Zohar J et al:Anxiety disorders:a review of tricyclic antidepressants and selective serotonin reuptake inhibitors. Acta Psychiatr Scand 101(suppl 403):S39-S49, 2000
 
3) 井上猛ほか:不安におけるセロトニン作動性神経系の機能的役割. 脳と精神の医学 14:199-207, 2003
 
4) Nutt DJ et al:Brain mechanisms of social anxiety disorder. J Clin Psychiatry 59(suppl 17):S4-S11, 1998
 
5) Heimberg RG:Cognitive-behavioral therapy for social anxiety disorder:current status and future directions. Biol Psychiatry 51:101-108, 2002
PubMed
6) 井上猛ほか:難治性うつ病の治療戦略とその前シナプス性作用機序. 日本神経精神薬理学雑誌 23:11-20, 2003
 
7) Inoue T et al:Effect of conditioned fear stress on serotonin metabolism in the rat brain. Pharmacol Biochem Behav 44:371-374, 1993
PubMed
8) Inoue T et al:Regional changes in dopamine and serotonin activation with various intensity of physical and psychological stress in the rat brain. Pharmacol Biochem Behav 49:911-920, 1994
PubMed
9) Inoue T et al:Serotonergic activation reduces defensive freezing in the conditioned fear paradigm. Pharmacol Biochem Behav 53:825-831, 1996
PubMed
10) Hashimoto S et al:Serotonin reuptake inhibitors reduce conditioned fear stress-induced freezing behavior in rats. Psychopharmacology 123:182-186, 1996
PubMed
11) Inoue T et al:Serotonergic neurotransmission and defensive freezing in the conditioned fear stress paradigm. In:Affective Minds, ed. by Hatano G et al, Elsevier Science, Amsterdam, 2000, pp. 91-100
 
12) Borsini F et al:Do animal models of anxiety predict anxiolytic-like effects of antidepressants? Psychopharmacology 163:121-141, 2002
PubMed
13) Hashimoto S et al:Effects of conditioned fear stress on serotonin neurotransmission and freezing behavior in rats. Eur J Pharmacol 378:23-30, 1999
PubMed
14) Inoue T et al:Selective serotonin reuptake inhibitor reduces conditioned fear through its effect in the amygdala. Eur J Pharmacol 497:311-316, 2004
PubMed
15) 泉剛ほか:選択的セロトニン再取り込み阻害薬 (SSRI) の作用脳部位・作用機序に関する研究. 精神薬療基金研究年報 36:11-17, 2004
 
16) Stutzmann GE et al:Serotonin modulation of sensory inputs to the lateral amygdala:dependency on corticosterone. J Neurosci 18:9529-9538, 1998
 
17) Tillfors M et al:Cerebral blood flow in subjects with social phobia during stressful speaking tasks:a PET study. Am J Psychiatry 158:1220-1226, 2001
PubMed
18) Furmark T et al:Common changes in cerebral blood flow in patients with social phobia treated with citalopram or cognitive-behavioral therapy. Arch Gen Psychiatry 59:425-433, 2002
PubMed
19) Amaral DG:The primate amygdala and the neurobiology of social behavior:implications for understanding social anxiety. Biol Psychiatry 51:11-17, 2002
PubMed
20) Helmuth L:Cognitive neuroscience. Fear and trembling in the amygdala. Science 300:568-569, 2003
PubMed
21) Haxby JV:Human neural systems for face recognition and social communication. Biol Psychiatry 51:59-67, 2002
PubMed
22) Stahl SM:Independent actions on fear circuits may lead to therapeutic synergy for anxiety when combining serotonergic and GABAergic agents. J Clin Psychiatry 63:854-855, 2002
PubMed

書評

最近チェックした商品履歴

Loading...